Danish drugmaker Novo Nordisk (NOV: N) has asked the US Food and Drug Administration regulator to assess a stronger 7.2 mg ...

US biotech Lunai Bioworks (Nasdaq: LNAI) has signed its first letter of intent to license its off-the-shelf immune cell ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Swiss pharma giant Roche’s Itovebi ...

Spanish plasma-derived medicines company Grifols today announced the appointment of Tomás Dagá, Grifols’ board member, as ...

The global market for intratumoral cancer therapies is set for a long growth runway, according to new sector analysis from ...

Japanese drug developer Renalys Pharma yesterday announced positive top-line results from its Phase III clinical study of ...

Further to the announcement under Rule 2.7 of the Irish Takeover Rules by Avadel and Alkermes on November 19, 2025, Danish ...

US biotech Kura Oncology (Nasdaq: KURA) and Japanese specialty pharma Kyowa Kirin (TSE: 4151) have secured early guideline ...

The UK BioIndustry Association (BIA) has welcomed key measures in yesterday’s Autumn Budget that that broadly support the ...

Australia’s Therapeutic Goods Administration (TGA) has issued a safety warning regarding the discontinuation of Prolia ...

A public biotech company developing cell-encapsulation therapies using its live-cell encapsulation platform to treat cancer, ...

California, USA-based biotech Vera Therapeutics has announced the submission of a Biologics License Application (BLA) to the ...